“…Cortical thickness quantification obtained from magnetic resonance imaging (MRI) can be used to examine regional variations of the cerebral cortex that have been associated with normal aging and dementia due to neurodegeneration (Fischl and Dale, 2000;Salat et al, 2004;Lerch and Evans, 2005;Raamana et al, 2015;Redolfi et al, 2015). Cortical thinning in specific topographical regions of the brain has been used to accurately determine patterns of neurodegeneration in mild cognitive impairment (MCI) (Raamana et al, 2014), Alzheimer's disease (AD), frontotemporal dementia (FTD) (Du et al, 2007;Lerch et al, 2008;Bakkour et al, 2009;Richards et al, 2009;Cho et al, 2012;Hartikainen et al, 2012;Paternicó et al, 2016;Vuksanović et al, 2019), Parkinson's disease (Uribe et al, 2016;Gao et al, 2018;Yau et al, 2018;Wilson et al, 2019), amyotrophic lateral sclerosis (ALS) (Verstraete et al, 2012;Mezzapesa et al, 2013;Schuster et al, 2014;Walhout et al, 2015), and vascular cognitive impairment (Seo et al, 2010;Kim et al, 2014;Jung et al, 2018).…”